Results 231 to 240 of about 3,019,224 (363)
This study develops a diagnostic platform for early detection of esophageal squamous cell carcinoma (ESCC) by integrating a barcode immunoassay biochip with machine learning. The biochip captures and analyzes small extracellular vesicle proteins from serum samples, identifying nine biomarkers linked to ESCC.
Xue Zhang+14 more
wiley +1 more source
Liquid Biopsy: Current advancements in clinical practice for bladder cancer. [PDF]
Crocetto F+17 more
europepmc +1 more source
Systematic liquid biopsy identifies novel and heterogeneous mechanisms of acquired resistance in gastrointestinal (GI) cancer patients [PDF]
Aparna Parikh+17 more
openalex +1 more source
Here, it is revealed that CAF‐secreted exosomal CCT6A enhances stemness, chemoresistance, and glycolysis in GC via the β‐catenin/c‐Myc/DDIT4‐TXNIP axis. Furthermore, CCT6P1, a pseudogene of CCT6A, is identified as upregulating CCT6A by competitively binding miR‐922, while c‐Myc transcriptionally activates both CCT6P1 and CCT6A.
Hui Sun+15 more
wiley +1 more source
Liquid Biopsy in Solid Tumours: An Overview. [PDF]
Pisapia P+3 more
europepmc +1 more source
Stroma Liquid Biopsy™ - A Proteomic Model of the Systemic Response to Cancer [PDF]
Matthew Kuruc
openalex +1 more source
This study determines the maximum tolerated dose of lenvatinib in combination with paclitaxel as second‐line therapy for advanced gastric cancer patients. A dynamic network biomarker panel associated with patient prognosis and response to treatment is established.
Chenfei Zhou+8 more
wiley +1 more source
The advances of DNA methylation in the liquid biopsy for the detection of lung cancer. [PDF]
Chen Y, Peng S, Wang C.
europepmc +1 more source